Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
Top Cited Papers
- 1 February 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9613), 660-667
- https://doi.org/10.1016/s0140-6736(08)60304-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT RegistryClinical Gastroenterology and Hepatology, 2006
- Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled TrialGastroenterology, 2006
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2004
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's diseaseGastroenterology, 1999
- A controlled double blind study of azathioprine in the management of Crohn's disease.Gut, 1995
- Frequency of glucocorticoid resistance and dependency in Crohn's disease.Gut, 1994
- Clinical, biological, and endoscopic picture of attacks of Crohn's diseaseGastroenterology, 1990
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980